Clinical guidelines "Multiple Sclerosis", 2024 (based on the results of discussion at the 5th Congress of ROKIRS, Ufa on September 30, 2023 and at the Presidium of the WON on December 25, 2024

Clinical guidelines "Optcomyelitis optica (Devic's disease, neuromyelitis optica spectrum diseases)", 2023 (draft)

Patients with multiple sclerosis in the context of the COVID-19 pandemic

British Association of Neurology Guidelines

Recommendations of the Italian Multiple Sclerosis Society

Recommendations of the International Federation of Multiple Sclerosis Societies

ABN GUIDANCE ON THE USE OF DISEASE-MODIFYING THERAPIES IN MULTIPLE SCLEROSIS IN RESPONSE TO THE THREAT OF A CORONAVIRUS EPIDEMIC

Coronavirus SARS-CoV-2: Hinweise zur Anwendung von MS-Immuntherapeutika Stellungnahme des Kompetenznetz Multiple Sklerose e. V.

Guidelines for neurological disorders immuntherapy and COVID19

Resolution of the round table on the topic "Improvement of the legislation of the Russian Federation on the provision of medical care to patients with neurological diseases (multiple sclerosis, Alzheimer's disease and others)" 15.06.2022